Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate

Author(s):  Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R

Issue:  Jul/Aug 2011 - Volume 15, Number 4
View All Articles in Issue

Page(s):  344-349

Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Page 1
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Page 2
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Page 3
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Page 4
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Page 5
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate Page 6

Download in electronic PDF format for $75

Abstract:  Sodium p-aminosalicylate is an orphan drug used in patients affected with multidrug-resistant tuberculosis. In this article, the preparation and characterization of a new alternative formulation of p-aminosalicylate is described. It consists of a powder for extemporaneous reconstitution, p-aminosaliyilate–extemporaneous, to be orally administered in solution. It is finally packaged in a tightly closed, light-resistant glass container as a unitary dose. In order to promote accessibility to multidrug-resistant tuberculosis treatment, the formulation is low cost and simple to manufacture, being compounded with only four ingredients. To improve patient compliance and treatment adherence, the unpleasant taste of p-aminosalicylate was masked as p-aminosalicylate–extemporaneous, which is easier to drink. The p-aminosalicylate–extemporaneous was characterized in relation to its content uniformity, time of blending, powder bulk properties (flowability), and stability. The proposed alternative formulation remained stable in its final containers for 3 months, as demonstrated by analytical assays and flowability properties.

Related Keywords: sodium p-aminosalicylate, multidrug-resistant tuberculosis, formulation, drug resistance, patient compliance, extemporaneous reconstitution, bulk powder, stability, packaging, Argentina

Related Categories: FORMULATIONS, PACKAGING, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate
Hergert Lisandro Y
, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
Jul/Aug 2011
Pg. 344-349

Validation of Ultraviolet-visible and High-performance Liquid Chromatographic Methods for the Determination of Sodium p-Aminosalicylate and m-Aminophenol in a New Pharmaceutical Formulation
Hergert Lisandro Y
, Ravetti Soledad, Mazzieri Maria R
Jan/Feb 2016
Pg. 63-70

The Basics of Compounding Powders and Granules
Allen Loyd V Jr
Jan/Feb 2001
Pg. 36-39

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Extemporaneous Formulations in Pediatric Patients
Nahata Milap C
Jul/Aug 1999
Pg. 274-276

Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Zhang Yanping
, Trissel Lawrence A
May/Jun 2002
Pg. 226-229

Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution
Alexander Kenneth S
, Kaushik Sarita
Mar/Apr 2004
Pg. 147-152

Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Gupta Vishnu D
Jul/Aug 2003
Pg. 310-312

Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Chauhan Nikita N
, Patel Jayvadan K
Jan/Feb 2023
Pg. 60-71

Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser
, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Nov/Dec 2021
Pg. 523-527

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
Jan/Feb 2001
Pg. 9-12

Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
Jan/Feb 2011
Pg. 71

Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.
Xu Quanyun A
, Trissel Lawrence A, Pham Lien
May/Jun 2004
Pg. 228-230

Formulation and Stability of Solutions
Akers Michael J
Mar/Apr 2016
Pg. 137-141

Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina
, Baskett Dustin
Sep/Oct 2018
Pg. 387-398

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut
, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022
Pg. 150-154

Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
Sep/Oct 2022
Pg. 370-377

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Return to Top